Ativan Related Published Studies
Well-designed clinical trials related to Ativan (Lorazepam)
Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical
trial. [2014]
Intravenous promethazine versus lorazepam for the treatment of peripheral vertigo
in the emergency department: A double blind, randomized clinical trial of
efficacy and safety. [2014]
A comparative study of fixed tapering dose regimen versus symptom-triggered
regimen of lorazepam for alcohol detoxification. [2014]
A double blind randomised comparison of chlordiazepoxide and lorazepam in alcohol
withdrawal. [2013]
RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. [2011.10]
Lorazepam effects on Word Memory Test performance: a randomized, double-blind, placebo-controlled, crossover trial. [2011.07]
Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. [2011.04]
Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam. [2011.02]
One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. [2011.01]
RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind
randomized clinical trial of the efficacy of intramuscular midazolam versus
intravenous lorazepam in the prehospital treatment of status epilepticus by
paramedics. [2011]
Pharmacodynamic differentiation of lorazepam sleepiness and dizziness using an ordered categorical measure. [2010.08]
Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study. [2010.06]
Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia. [2010.06]
Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge. [2010.05]
Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial. [2010.03]
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. [2010.02]
A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. [2010.02]
Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. [2010]
The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study. [2009.11.30]
The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers. [2009.08]
A randomized, double-blind comparison of lorazepam and chlordiazepoxide in patients with uncomplicated alcohol withdrawal. [2009.05]
Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: A randomized controlled trial. [2009.03.16]
The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge. [2008.11]
Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. [2008.03]
Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. [2008.01.02]
Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials. [2008.01]
Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. [2007.12.12]
Propofol associated with a shorter duration of mechanical ventilation than scheduled intermittent lorazepam: a database analysis using Project IMPACT. [2007.12]
Effects of lorazepam on deductive reasoning. [2007.11]
Lorazepam induces multiple disturbances in selective attention: attentional overload, decrement in target processing efficiency, and shifts in perceptual discrimination and response bias. [2007.09]
Efficacy and Tolerability of a Standardized Herbal Product from Galphimia glauca on Generalized Anxiety Disorder. A Randomized, Double-Blind Clinical Trial Controlled with Lorazepam. [2007.07]
Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes. [2007.06]
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. [2007.06]
Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. [2007.02.15]
A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers. [2007.01]
Lorazepam dose-dependently decreases risk-taking related activation in limbic areas. [2006.11]
Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine. [2006.11]
Effects of the amnesic drug lorazepam on complete and partial information retrieval and monitoring accuracy. [2006.11]
GABAergic modulation of diffuse noxious inhibitory controls (DNIC): a test by use of lorazepam. [2006.11]
Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. [2006.05.13]
A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. [2006.05]
Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration. [2006.05]
Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. [2006.04]
Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial. [2006.03]
Some facilitatory effects of lorazepam on dynamic visual binding. [2006.01]
Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine. [2005.11]
Gender differences in response to lorazepam in a human drug discrimination study. [2005.11]
Effects of lorazepam on fear-potentiated startle responses in man. [2005.05]
Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. [2005.04.15]
Anterior limbic alpha-like activity: a low resolution electromagnetic tomography study with lorazepam challenge. [2005.04]
Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. [2005.03]
Specific effects of an amnesic drug: effect of lorazepam on study time allocation and on judgment of learning. [2005.01]
Well-designed clinical trials possibly related to Ativan (Lorazepam)
The effects of subanesthetic ketamine infusions on motivation to quit and
cue-induced craving in cocaine-dependent research volunteers. [2014]
Lessons from the RAMPART study--and which is the best route of administration of
benzodiazepines in status epilepticus. [2013]
An orally administered lavandula oil preparation (Silexan) for anxiety disorder
and related conditions: an evidence based review. [2013]
Intranasal oxytocin blocks alcohol withdrawal in human subjects. [2013]
Lack of efficacy of L-759274, a novel neurokinin 1 (substance P) receptor
antagonist, for the treatment of generalized anxiety disorder. [2013]
Aripiprazole versus olanzapine in the treatment of schizophrenia: a clinical
study from India. [2013]
Intramuscular versus intravenous therapy for prehospital status epilepticus. [2012]
Rapid acute treatment of agitation in patients with bipolar I disorder: a
multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. [2012]
treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial. [2011.10]
Prophylactic analgesia before percutaneous liver biopsy: a clinical comparative study. [2011.09]
Intrauterine lidocaine infusion for pain management during outpatient transcervical tubal sterilization: a randomized controlled trial. [2011.08.17]
Benefit effect of naloxone in benzodiazepines intoxication: findings of a preliminary study. [2011.07]
A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal. [2011.05]
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. [2011.01]
Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. [2011]
Treating alcohol withdrawal with oral baclofen: a randomized, double-blind,
placebo-controlled trial. [2011]
Rapid acute treatment of agitation in individuals with schizophrenia:
multicentre, randomised, placebo-controlled study of inhaled loxapine. [2011]
Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study. [2010.06]
The complex interplay between delirium, sepsis and sedation. [2010]
Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in The Netherlands. [2010]
Psychometric evaluation of a visual analog scale for the assessment of anxiety. [2010]
Effect of hypnotic drugs on body balance and standing steadiness. [2010]
An electronic regulatory document management system for a clinical trial network. [2010]
Comparative efficacy of pregabalin and benzodiazepines in treating the psychic
and somatic symptoms of generalized anxiety disorder. [2010]
Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. [2009.11]
Benzodiazepines for delirium. [2009.10.07]
Effects of pregabalin on post operative morphine consumption and pain after abdominal hysterectomy with/without salphingo-oophorectomy: a randomized, double-blind trial. [2009.10]
Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. [2009.07.09]
Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial. [2009.05]
Differing effects of intracortical circuits on plasticity. [2009.03]
Oral compared with intravenous sedation for first-trimester surgical abortion: a randomized controlled trial. [2009.02]
Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. [2009.02]
Benzodiazepines for delirium. [2009.01.21]
Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder. [2009.01]
Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. [2008.12]
Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. [2008.07.16]
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.06]
Effect of pharmacological treatment on temperament and character in panic disorder. [2008.03.15]
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. [2008.03]
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. [2007.10]
Review: Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. [2007.09]
The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions. [2007.08]
A randomized trial comparing local intracervical and combined local and paracervical anesthesia in outpatient hysteroscopy. [2007.03]
Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia. [2007.02]
Role of lormetazepam in the treatment of insomnia in the elderly. [2007]
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. [2006.07]
Sedation and memory: studies with a histamine H-1 receptor antagonist. [2006.07]
Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust. [2006.05]
Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. [2006.01]
|
